Skip to main content

Prognostic Factors for Survival in Multiple System Atrophy


An 88 year-old male with probable multiple system atrophy-parkinsonism (MSA-P) with at least 4 years of gait instability complicated by fall and cervical fracture, sick sinus syndrome status post pacemaker placement, postural hypotension requiring midodrine and fludrocortisone, achalasia status post BOTOX® injection and dilation, urinary retention status post chronic indwelling Foley catheter presented to the Geriatrics outpatient clinic to explore hospice care. In a brief background search of MSA, I found that there are 2 distinct presentations of MSA – cerebellar and parkinsonian. In discussing his prognosis with the patient, I wondered if in patients with MSA, does parkinsonism phenotype predict better survival than the cerebellar phenotype? And are there other disease specific or patient specific features that predict survival in MSA patients? 


I searched the terms “multiple system atrophy, survival” on PubMed Clinical Queries (website url), which I have often found more useful than regular PubMed general search. To narrow my results, I selected the “Prognosis” category and “Broad” scope for the search. I found a systematic review of pathologically confirmed cases of MSA identified through search of MEDLINE and other published reference lists from 1887 to 2/1995.

Individual patient data was reviewed, although there was no mention about assessment for validity of the individuals case reports and case series. Of the total of 433 cases included in the analysis, 358 cases were reported from 1971 through 1994. Chi-squared test for heterogeneity showed significant heterogeneity in age of onset, autonomic features, parkinsonian features, pyramidal features and MSA type across the board. The mean age onset was at 54.2 years of age, and mean survival around 6 years. Majority of the cases (> 80%) had autonomic features or parkinsonism.

The only significant predictor of increased survival were younger age at onset, more recent publication, and presence of cerebellar features. The results were not altered when accounting for the life expectancy of the general population over time from 1887 through 1970 and from 1971 through 1994. There was a trend toward worse survival when the case had more than one clinical features (parkinsonism, autonomic, cerebellar, pyramidal)

Back to the Patient: Using the information from this systematic review and patient’s clinical picture of likely at least a 4 year of disease duration and multiple clinical features, his clinical presentation confers to worse survival. When this was discussed with him and his family, in light of his rapid functional decline over the last 10 months, our patient agreed to enroll into hospice.

Take-home Points:
1. Age of onset for MSA is around 54 years. Older age of onset is a predictor for worse survival.

2. Cerebellar predominant feature is a predictor for increased survival.

3. Recent publication date is a predictor for increased survival, although there may be unaccounted confounder not included in this analysis. Clinical relevance of this finding is limited.

by: Pei Chen, MD
Department of Geriatrics and Palliative Medicine
Icahn School of Medicine at Mount Sinai

This post is part of the #GeriCases series, in which we discuss a clinical case in geriatrics and the attempt to provide patient-centered care with the use of best available evidence. 

Picture courtesy: Paco CT

Ravishankar Ramaswamy, MD
@RavRamaswamy
Section Editor, #GeriCases

Comments

Anonymous said…
Please see New England Journal of Medicine review article on Multiple System Atrophy - January 15, 2015

https://www.facebook.com/ProfGregorKWenning

http://www.nejm.org/doi/full/10.1056/NEJMra1311488

Popular posts from this blog

Practical Advice for the End of Life: A Podcast with BJ Miller

This week we talk with BJ Miller, hospice and palliative care physician, public speaker, and now author with Shoshana Berger of the book "A Beginner's Guide to the End."

As we note on the podcast, BJ is about as close as we get to a celebrity in Hospice and Palliative Care.  His TED Talk "What Really Matters at the End of Life" has been viewed more than 9 million times.  As we discuss on the Podcast, this has changed BJ's life, and he spends most of his working time engaged in public speaking, being the public "face" of the hospice and palliative care movement.

The book he and Berger wrote is filled to the brim with practical advice.  I mean, nuts and bolts practical advice.  Things like:
How to clean out not only your emotional house but your physical house (turns out there are services for that!)Posting about your illness on social media (should you post to Facebook)What is the difference between a funeral home and mortuaryCan I afford to die?  …

Improving Advance Care Planning for Latinos with Cancer: A Podcast with Fischer and Fink

In this week's GeriPal podcast we talk with Stacy Fischer, MD and Regina Fink, RN, PhD, both from the University of Colorado, about a lay health navigator intervention to improve advance care planning with Latinos with advanced cancer.  The issue of lay health navigators raises several issues that we discuss, including:
What is a lay health navigator?What do they do?  How are they trained?What do lay health navigators offer that specialized palliative care doesn't?  Are they replacing us?What makes the health navigator intervention particularly appropriate for Latinos and rural individuals?  For advance care planning? Eric and I had fun singing in French (yes French, not Spanish, listen to the podcast to learn why).
Enjoy! -@AlexSmithMD




You can also find us onYoutube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher

Transcript

Eric: Welcome to the GeriPal podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: And Alex, I'm really excited about toda…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …